Owens&Minor Investor Conference Presentation Deck
Apria Acquisition - Strategic Rationale
Expands Patient Direct Segment and Recurring Revenue
Well-positioned across key product categories exposed to
strong underlying growth drivers
8
♫
Expands offerings across chronic and acute conditions, with
opportunities to treat overlapping conditions for patients
Enhanced geographic reach
Payor relationship growth
Brings greater efficiency to the home healthcare supply market
History of strong performance by the Byram team instills
confidence and excitement around Apria acquisition
Track record of profitable growth and value creation by Apria
team
Byram
HEALTHCARE
Patient Direct Product Lines
0%,
Home Respiratory
Obstructive Sleep Apnea
Negative Pressure Wound Therapy
HME & Other Services
Diabetes
Ostomy
Incontinence
Traditional Wound Care
Urology
Breast Pumps
main
APRIA
Approximately 50% of all type 2 diabetics and ~80% of all those with clinically diagnosed obesity experience sleep apnea, a chronic condition.
✓ Significant opportunities for cross-selling of products from Apria and Byram, simplifying the patient, payor, and provider experience
Owens
M&MinorView entire presentation